The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism ; volume:9 ; number:1 ; day:21 ; month:10 ; year:2011 ; pages:1-11 ; date:12.2011
Journal of translational medicine ; 9, Heft 1 (21.10.2011), 1-11, 12.2011
- Creator
-
Eudy, Rena J.
- Contributor
-
Sahasrabudhe, Vaishali
Sweeney, Kevin
Tugnait, Meera
King-Ahmad, Amanda
Near, Kristen
Loria, Paula
Banker, Mary Ellen
Piotrowski, David W.
Boustany-Kari, Carine M.
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-9-180
- URN
-
urn:nbn:de:1111-2016041436716
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eudy, Rena J.
- Sahasrabudhe, Vaishali
- Sweeney, Kevin
- Tugnait, Meera
- King-Ahmad, Amanda
- Near, Kristen
- Loria, Paula
- Banker, Mary Ellen
- Piotrowski, David W.
- Boustany-Kari, Carine M.
- SpringerLink (Online service)
Other Objects (12)
Effect of Mineralocorticoid receptor antagonism (MRA) on aldosterone-interleukin 6 axis in heart failure; second opinion. A case-control study
Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage
Mineralocorticoid-receptor antagonism and its metabolic consequences in haemodialysis patients
Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke
A Podcast Discussing Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm Shift
Chemokine receptor CXCR7 antagonism ameliorates cardiac and renal fibrosis induced by mineralocorticoid excess
Sex-specific responses to mineralocorticoid receptor antagonism in hypertensive African American males and females
P10.03 Endothelium-Specific Calcium-Activated Potassium Channels: Targets for Aldosterone
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data
Salivary Aldosterone, Central and Peripheral Mineralocorticoid Receptor Function and Their Impact on the Course of Depression
The tubulogenic effect of aldosterone is attributed to intact binding and intracellular response of the mineralocorticoid receptor
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Effect of Mineralocorticoid receptor antagonism (MRA) on aldosterone-interleukin 6 axis in heart failure; second opinion. A case-control study
Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage
Mineralocorticoid-receptor antagonism and its metabolic consequences in haemodialysis patients
Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke
A Podcast Discussing Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm Shift
Chemokine receptor CXCR7 antagonism ameliorates cardiac and renal fibrosis induced by mineralocorticoid excess
Sex-specific responses to mineralocorticoid receptor antagonism in hypertensive African American males and females
P10.03 Endothelium-Specific Calcium-Activated Potassium Channels: Targets for Aldosterone
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data
Salivary Aldosterone, Central and Peripheral Mineralocorticoid Receptor Function and Their Impact on the Course of Depression
The tubulogenic effect of aldosterone is attributed to intact binding and intracellular response of the mineralocorticoid receptor
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Effect of Mineralocorticoid receptor antagonism (MRA) on aldosterone-interleukin 6 axis in heart failure; second opinion. A case-control study
Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage
Mineralocorticoid-receptor antagonism and its metabolic consequences in haemodialysis patients
Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke
A Podcast Discussing Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm Shift
Chemokine receptor CXCR7 antagonism ameliorates cardiac and renal fibrosis induced by mineralocorticoid excess
Sex-specific responses to mineralocorticoid receptor antagonism in hypertensive African American males and females
P10.03 Endothelium-Specific Calcium-Activated Potassium Channels: Targets for Aldosterone
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data
Salivary Aldosterone, Central and Peripheral Mineralocorticoid Receptor Function and Their Impact on the Course of Depression
The tubulogenic effect of aldosterone is attributed to intact binding and intracellular response of the mineralocorticoid receptor